PD-1/PD-L1-IN-42 (Compound B8.4) is an inhibitor of the interaction between PD-1 and PD-L1, with an EC50 of 0.1 µM. PD-1/PD-L1-IN-42 can be used for the research of cancer immunotherapy[1].
Molecular Weight:
1861.13
Formula:
C85H129N21O24S
Target:
PD-1/PD-L1
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted